Vertex Pharmaceuticals

NASDAQ: VRTX · Real-Time Price · USD
391.78
1.48 (0.38%)
At close: Aug 15, 2025, 3:02 PM

Vertex Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-193.61 28.97 22.26 24.16
PEG Ratio
1.69 3.48 0.52 -1.87
PS Ratio
9.41 10.62 8.28 7.47
PB Ratio
6.32 5.96 5.32 5.60
P/FCF Ratio
-131.21 31.98 18.84 23.50
P/OCF Ratio
-210.51 29.64 17.91 21.41
OCF/S Ratio
-0.04 0.36 0.46 0.35
Debt / Equity Ratio
0.11 0.05 0.06 0.10
Quick Ratio
2.35 3.78 4.66 4.30
Current Ratio
2.69 3.99 4.83 4.46
Asset Turnover
0.49 0.43 0.49 0.56
Interest Coverage
-7.61 86.89 78.60 45.24
Return on Equity
-0.03 0.21 0.24 0.23
Return on Assets
-0.02 0.16 0.18 0.17
Return on Invested Capital
0.03 0.16 0.22 0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.86 0.87 0.88 0.88
Net Profit Margin
-0.05 0.37 0.37 0.31
Pretax Profit Margin
0.02 0.44 0.47 0.36
Operating Profit Margin
-0.02 0.39 0.48 0.37
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.04 0.47 0.50 0.39